India to United States: Azithromycin Export Trade Route
India has recorded 636 verified shipments of Azithromycin exported to United States, representing a combined trade value of $26.5M USD. This corridor is served by 27 active Indian exporters, with an average shipment value of $41.6K USD. The leading Indian exporter is LUPIN LIMITED, which accounts for 29% of total export value with 145 shipments worth $7.8M USD. On the buying side, UPS SUPPLY CHAIN SOLUTIONS is the largest importer in United States with $7.8M USD in purchases. The top 3 suppliers — LUPIN LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, ZYDUS LIFESCIENCES LIMITED — together control 69% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Azithromycin corridor is one of India's established pharmaceutical export routes, with 636 shipments documented worth a combined $26.5M USD. The route is dominated by LUPIN LIMITED, which alone accounts for roughly 29% of all export value, reflecting the consolidated nature of India's azithromycin manufacturing sector.
Across 27 active suppliers, the average shipment value stands at $41.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with azithromycin's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 16.4%, placing it at rank #2 among India's top azithromycin export destinations globally.
On the import side, key buyers of Indian azithromycin in United States include UPS SUPPLY CHAIN SOLUTIONS, EVERSANA LIFE SCIENCE SERVICES, J. KNIPPER & COMPANY and 91 others. UPS SUPPLY CHAIN SOLUTIONS is the single largest importer with 142 shipments valued at $7.8M USD.
Route Characteristics
- Average transit29 days
- Peak seasonQ2
- Primary modeSea freight
- Top portMUNDRA SEA
Market Position
- Global rank#2
- Annual growth+16.4%
- Demand growth+14.2%
- Regulatory ease89/100
Top 10 Indian Azithromycin Exporters to United States
Showing top 10 of 27 Indian suppliers exporting Azithromycin to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LUPIN LIMITED Avg $53.7K per shipment | 145 | $7.8M | 29.4% |
| 2 | ALEMBIC PHARMACEUTICALS LIMITED Avg $48.1K per shipment | 121 | $5.8M | 22.0% |
| 3 | ZYDUS LIFESCIENCES LIMITED Avg $40.4K per shipment | 115 | $4.6M | 17.6% |
| 4 | EUGIA PHARMA SPECIALITIES LIMITED Avg $66.3K per shipment | 63 | $4.2M | 15.8% |
| 5 | AUROBINDO PHARMA LIMITED Avg $33.7K per shipment | 27 | $908.8K | 3.4% |
| 6 | CADILA HEALTHCARE LIMITED Avg $46.8K per shipment | 19 | $889.3K | 3.4% |
| 7 | AUROBINDO PHARMA LTD Avg $32.6K per shipment | 27 | $879.8K | 3.3% |
| 8 | GLAND PHARMA LTD Avg $51.2K per shipment | 16 | $818.4K | 3.1% |
| 9 | GLAND PHARMA LIMITED Avg $107.8K per shipment | 3 | $323.5K | 1.2% |
| 10 | CADILA HEALTHCARE LTD Avg $38.1K per shipment | 3 | $114.3K | 0.4% |
This table shows the top 10 of 27 Indian companies exporting azithromycin to United States, ranked by total trade value. The listed exporters are: LUPIN LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, ZYDUS LIFESCIENCES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, AUROBINDO PHARMA LIMITED, CADILA HEALTHCARE LIMITED, AUROBINDO PHARMA LTD, GLAND PHARMA LTD, GLAND PHARMA LIMITED, CADILA HEALTHCARE LTD. LUPIN LIMITED is the dominant supplier with 145 shipments worth $7.8M USD, giving it a 29% market share. The top 3 suppliers together account for 69% of the total trade value on this route.
Showing top 10 of 27 total Indian exporters on the India to United States Azithromycin export route.
Top 10 Azithromycin Importers in United States
Showing top 10 of 94 known buyers in United States receiving Azithromycin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian azithromycin in United States include UPS SUPPLY CHAIN SOLUTIONS, EVERSANA LIFE SCIENCE SERVICES, J. KNIPPER & COMPANY, EUGIA US LLC, EUGIA US LLC,, among 94 total buyers. The largest importer is UPS SUPPLY CHAIN SOLUTIONS, accounting for $7.8M USD across 142 shipments — representing 29% of all azithromycin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | UPS SUPPLY CHAIN SOLUTIONS | 142 | $7.8M | 29.4% |
| 2 | EVERSANA LIFE SCIENCE SERVICES | 137 | $5.6M | 21.3% |
| 3 | J. KNIPPER & COMPANY | 61 | $2.7M | 10.1% |
| 4 | EUGIA US LLC | 33 | $2.2M | 8.3% |
| 5 | EUGIA US LLC, | 30 | $2.0M | 7.5% |
| 6 | J KNIPPER COMPANY | 32 | $1.9M | 7.4% |
| 7 | XXROBXXDO XXARMXXUSAXXNC | 12 | $617.1K | 2.3% |
| 8 | J. KNIPPER & COMPANY, | 16 | $604.4K | 2.3% |
| 9 | EVERSANA | 12 | $601.9K | 2.3% |
| 10 | J.KNIPPER & COMPANY | 11 | $532.0K | 2.0% |
Showing top 10 of 94 Azithromycin importers in United States on this route.
Top 10 Azithromycin Formulations Imported by United States
Showing top 10 of 358 product formulations shipped on the India to United States Azithromycin route, ranked by trade value
United States imports a wide range of azithromycin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — AZITHROMYCIN FOR INJECTION USP 500MG/VIAL — accounts for $682.3K USD across 11 shipments. There are 358 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AZITHROMYCIN FOR INJECTION USP 500MG/VIAL | 11 | $682.3K | 2.6% |
| 2 | AZITHROMYCIN 250MG TABLETS (AZITHROMYCIN | 5 | $569.6K | 2.2% |
| 3 | AZITHROMYCIN USP 250MG 3X1X6T BLI APUS | 8 | $541.6K | 2.0% |
| 4 | AZITHROMYCIN FOR ORAL SUSPENSION USP 200 | 8 | $525.3K | 2.0% |
| 5 | AZITHROMYCIN USP 250MG 3X1X6T BLI APUSNOS | 15 | $501.7K | 1.9% |
| 6 | Azithromycin Tablets USP 250 mg Tab | 8 | $432.0K | 1.6% |
| 7 | PHARMA MEDICINE FOR HUMAN USE-AZITHROMYCIN FOR ORAL SUSPENSION USP 200 MG/5 ML1200MG BOTTLE-QTY-115,584 PAC-AS PER INVNOS | 6 | $365.1K | 1.4% |
| 8 | AZITHROMYCIN TABLETS USP 250MG US-R1 AZITHROMYCIN USP 250MG - 97992 BTL x 30TABS | 1 | $352.8K | 1.3% |
| 9 | AZITHROMYCIN FOR INJECTION 500 MG | 6 | $332.6K | 1.3% |
| 10 | AZITHROMYCIN 250MG TABLETS US- R1 (AZITHROMYCIN USP 250MG) - 274176 BOX x 6 TABS | 2 | $328.3K | 1.2% |
Showing top 10 of 358 Azithromycin formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 84%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
MUNDRA SEA handles the highest volume with 141 shipments. Transit time averages 29 days by sea.
Market Dynamics
India's azithromycin exports to United States are driven primarily by a handful of large-scale manufacturers. LUPIN LIMITED with 145 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 27 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — LUPIN LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, ZYDUS LIFESCIENCES LIMITED — together account for 69% of total trade value on this route. The average shipment value of $41.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as azithromycin 250mg tablets (azithromycin and azithromycin usp 250mg 3x1x6t bli apus, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, UPS SUPPLY CHAIN SOLUTIONS is the largest importer with 142 shipments worth $7.8M USD — representing 29% of all azithromycin imports from India on this route. A total of 94 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $26.5M
- Avg. Shipment
- $41.6K
- Suppliers
- 27
- Buyers
- 94
- Transit (Sea)
- ~29 days
- Annual Growth
- +16.4%
Related Analysis
Reverse Direction
United States → India — Azithromycin (Import)Other Azithromycin Routes
Azithromycin — Export Intelligence Video
Visual overview of India's azithromycin India to United States export trade route — top suppliers, destinations, pricing, and trade routes
Unlock the Full India to United States Azithromycin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 636 shipments on this route.
Frequently Asked Questions — India to United States Azithromycin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Azithromycin to United States?
The leading Indian exporters of Azithromycin to United States are LUPIN LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, ZYDUS LIFESCIENCES LIMITED. LUPIN LIMITED holds the largest market share at approximately 29% of total trade value on this route.
Q What is the total value of Azithromycin exports from India to United States?
India exports Azithromycin to United States worth approximately $26.5M USD across 636 recorded shipments. The average value per shipment is $41.6K USD.
Q Which ports does India use to ship Azithromycin to United States?
The most active port of origin is MUNDRA SEA with 141 shipments. Indian exporters primarily use sea freight for this route, with 84% of shipments going by sea and 29% by air.
Q How long does shipping take from India to United States for Azithromycin?
The average transit time for Azithromycin shipments from India to United States is approximately 29 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to United States Azithromycin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 16.4% with demand growth tracking at 14.2%. The route is ranked #2 among India's top Azithromycin export destinations globally.
Q How many suppliers are active on the India to United States Azithromycin route?
There are currently 27 active Indian suppliers exporting Azithromycin to United States. The market is moderately concentrated with LUPIN LIMITED accounting for 29% of total shipment value.
Q Who are the main importers of Azithromycin from India in United States?
The leading importers of Indian Azithromycin in United States include UPS SUPPLY CHAIN SOLUTIONS, EVERSANA LIFE SCIENCE SERVICES, J. KNIPPER & COMPANY, EUGIA US LLC, EUGIA US LLC,. UPS SUPPLY CHAIN SOLUTIONS is the largest buyer with 142 shipments worth $7.8M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Azithromycin.
- 2.Supplier/Buyer Matching: 27 Indian exporters and 94 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 636 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
636 Verified Shipments
27 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists